This study evaluated the phytochemical constituents and potential antidiabetic properties of Peperomia pellucida using qualitative, quantitative, in vitro, and in vivo experimental approaches. Qualitative phytochemical screening revealed the presence of flavonoids, phenols, tannins, alkaloids, saponins, and glycosides, while terpenoids and phlobatannins were absent. Quantitative analysis confirmed high concentrations of total phenolics, flavonoids, tannins, and alkaloids. The extract also showed strong antioxidant potential through DPPH, ABTS, and total antioxidant capacity assays. In vitro antidiabetic evaluation indicated inhibitory effects on carbohydrate-hydrolyzing enzymes such as α-amylase and α-glucosidase, suggesting the ability of the extract to help modulate postprandial glucose levels. In vivo evaluation in diabetic animal models further supported hypoglycemic and antihyperglycemic effects of the plant extract. Overall, the findings support the traditional use of Peperomia pellucida in the management of diabetes mellitus and its associated oxidative stress. The study also suggests that the plant is rich in phytochemicals, particularly phenolics, flavonoids, tannins, and alkaloids, which contribute to its antioxidant and antidiabetic potential. Further molecular, toxicological, and clinical studies were recommended to validate its safety, efficacy, and mechanistic basis as a potential antidiabetic therapeutic agent.
File Type:
pdf
Categories:
Volume 5 No 1